Location History:
- King of Prussia, PA (US) (2002)
- Hillsborough, NJ (US) (2008 - 2022)
Company Filing History:
Years Active: 2002-2025
Title: **Liang Ma: Innovating Therapeutics**
Introduction
Liang Ma is a prominent inventor based in Hillsborough, NJ, USA, known for his contributions to the fields of pharmaceuticals and biotechnology. With a remarkable portfolio of five patents, he has made significant strides in developing innovative solutions for various health conditions.
Latest Patents
Liang Ma's latest inventions include breakthrough patents that focus on novel therapeutic compounds. One notable patent involves colony stimulating factor-1 receptor (CSF-1R) inhibitors, which are compounds specifically designed to inhibit CSF-1R, demonstrating potential for treating various diseases. Another significant invention pertains to pyrimidine amide compounds serving as PGDS inhibitors, providing new therapeutic avenues for allergic and inflammatory disorders, including conditions such as allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD).
Career Highlights
Throughout his career, Liang has collaborated with leading organizations in the pharmaceutical sector, including Aventis Pharmaceuticals Inc. and Genzyme Corporation. His tenure at these esteemed companies has allowed him to refine his expertise in drug development and innovate solutions that address unmet medical needs.
Collaborations
Liang has worked alongside accomplished professionals in the industry, including Jeffrey Stephen Sabol and Patrick Shum. These collaborations have not only fostered creativity and knowledge exchange but also propelled his inventive endeavors to new heights.
Conclusion
In summary, Liang Ma stands out as a dedicated innovator whose patent portfolio reflects his commitment to advancing therapeutic options through inventive solutions. His work represents a significant contribution to the medical field, and his ongoing efforts continue to inspire advancements in pharmaceutical science.